IQ EQ FUND MANAGEMENT IRELAND Ltd Acquires 1,139 Shares of Xylem Inc. $XYL

IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its holdings in shares of Xylem Inc. (NYSE:XYL) by 4.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 26,435 shares of the industrial products company’s stock after buying an additional 1,139 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Xylem were worth $3,420,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in XYL. Vanguard Group Inc. boosted its stake in shares of Xylem by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after acquiring an additional 362,127 shares in the last quarter. Swedbank AB lifted its holdings in Xylem by 13.9% in the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after purchasing an additional 531,890 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Xylem by 7.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock worth $480,767,000 after purchasing an additional 274,123 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after purchasing an additional 3,239,203 shares during the period. Finally, Northern Trust Corp grew its holdings in Xylem by 2.9% during the first quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock valued at $401,743,000 after purchasing an additional 94,560 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on XYL shares. Stifel Nicolaus boosted their price objective on shares of Xylem from $162.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. UBS Group boosted their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Mizuho upped their price target on shares of Xylem from $125.00 to $140.00 and gave the company a “neutral” rating in a report on Friday, September 12th. TD Cowen lifted their price objective on Xylem from $125.00 to $130.00 and gave the stock a “hold” rating in a research note on Tuesday, August 26th. Finally, Wall Street Zen upgraded Xylem from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average target price of $154.67.

Xylem Trading Up 0.8%

Xylem stock opened at $149.47 on Tuesday. The business has a 50 day moving average price of $143.96 and a two-hundred day moving average price of $133.19. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $151.16. The stock has a market cap of $36.38 billion, a price-to-earnings ratio of 38.82, a price-to-earnings-growth ratio of 2.53 and a beta of 1.13.

Xylem (NYSE:XYL) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion for the quarter, compared to analysts’ expectations of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.Xylem’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio is currently 41.56%.

Insider Activity at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares in the company, valued at approximately $413,861.72. The trade was a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.27% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.